AAAAAA
Results:
1-22
|
Results: 22
Authors:
Liechti, ME
Gamma, A
Vollenweider, FX
Citation: Me. Liechti et al., Gender differences in the subjective effects of MDMA, PSYCHOPHAR, 154(2), 2001, pp. 161-168
Authors:
Frei, E
Gamma, A
Pascual-Marqui, R
Lehmann, D
Hell, D
Vollenweider, FX
Citation: E. Frei et al., Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA), HUM BRAIN M, 14(3), 2001, pp. 152-165
Authors:
Vollenweider, FX
Jones, RT
Baggott, MJ
Citation: Fx. Vollenweider et al., Response: Caveat emptor: Editors beware, NEUROPSYCH, 24(4), 2001, pp. 461-463
Authors:
Liechti, ME
Geyer, MA
Hell, D
Vollenweider, FX
Citation: Me. Liechti et al., Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin, NEUROPSYCH, 24(3), 2001, pp. 240-252
Authors:
Gamma, A
Buck, A
Berthold, T
Vollenweider, FX
Citation: A. Gamma et al., No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine)users and control subjects: A [(H2O)-O-15]-positron emission tomography study, J CL PSYCH, 21(1), 2001, pp. 66-71
Authors:
Gamma, A
Frei, E
Lehmann, D
Pascual-Marqui, RD
Hell, D
Vollenweider, FX
Citation: A. Gamma et al., Mood state and brain electric activity in Ecstasy users, NEUROREPORT, 11(1), 2000, pp. 157-162
Authors:
Liechti, ME
Vollenweider, FX
Citation: Me. Liechti et Fx. Vollenweider, Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans, EUR NEUROPS, 10(4), 2000, pp. 289-295
Authors:
Gamma, A
Buck, A
Berthold, T
Liechti, ME
Vollenweider, FX
Citation: A. Gamma et al., 3,4-methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [(H2O)-O-15]-PET in healthy humans (vol 23, pg 388, 2000), NEUROPSYCH, 23(5), 2000, pp. 599-599
Authors:
Gamma, A
Buck, A
Berthold, T
Hell, D
Vollenweider, FX
Citation: A. Gamma et al., 3,4-methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [(H2O)-O-15]-PET in healthy humans, NEUROPSYCH, 23(4), 2000, pp. 388-395
Authors:
Liechti, ME
Saur, MR
Gamma, A
Hell, D
Vollenweider, FX
Citation: Me. Liechti et al., Psychological and physiological effects of MDMA ("ecstasy") after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans, NEUROPSYCH, 23(4), 2000, pp. 396-404
Authors:
Liechti, ME
Baumann, C
Gamma, A
Vollenweider, FX
Citation: Me. Liechti et al., Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram, NEUROPSYCH, 22(5), 2000, pp. 513-521
Authors:
Buck, A
Gucker, PM
Schonbachler, RD
Arigoni, M
Kneifel, S
Vollenweider, FX
Ametamey, SM
Burger, C
Citation: A. Buck et al., Evaluation of serotonergic transporters using PET and [C-11](+)McN-5652: Assessment of methods, J CEREBR B, 20(2), 2000, pp. 253-262
Authors:
Liechti, ME
Vollenweider, FX
Citation: Me. Liechti et Fx. Vollenweider, The serotonin uptake inhibitor citalopram reduces acute cardiovascular andvegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers, J PSYCHOPH, 14(3), 2000, pp. 269-274
Authors:
Vollenweider, FX
Vontobel, P
Oye, I
Hell, D
Leenders, KL
Citation: Fx. Vollenweider et al., Effects of (S)-ketamine on striatal dopamine: a [C-11]raclopride PET studyof a model psychosis in humans, J PSYCH RES, 34(1), 2000, pp. 35-43
Authors:
Vollenweider-Scherpenhuyzen, MFI
Vollenweider, FX
Citation: Mfi. Vollenweider-scherpenhuyzen et Fx. Vollenweider, Emergency cases in drug abuse, INTERNIST, 41(9), 2000, pp. 886-898
Authors:
Umbricht, D
Schmid, L
Koller, R
Vollenweider, FX
Hell, D
Javitt, DC
Citation: D. Umbricht et al., Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers - Implications for models of cognitive deficits in schizophrenia, ARCH G PSYC, 57(12), 2000, pp. 1139-1147
Authors:
Vollenweider, FX
Remensberger, S
Hell, D
Geyer, MA
Citation: Fx. Vollenweider et al., Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans, PSYCHOPHAR, 143(4), 1999, pp. 365-372
Authors:
Vollenweider, FX
Gamma, A
Liechti, M
Huber, T
Citation: Fx. Vollenweider et al., Is a single dose of MDMA harmless?, NEUROPSYCH, 21(4), 1999, pp. 598-600
Authors:
Vollenweider, FX
Vontobel, P
Hell, D
Leenders, KL
Citation: Fx. Vollenweider et al., 5-HT modulation of dopamine release in basal ganglia in psilocybin-inducedpsychosis in man - A PET study with [C-11]raclopride, NEUROPSYCH, 20(5), 1999, pp. 424-433
Authors:
Zessin, J
Gucker, P
Ametamey, SM
Steinbach, J
Brust, P
Vollenweider, FX
Johannsen, B
Schubiger, PA
Citation: J. Zessin et al., Efficient synthesis of enantiomerically pure thioester precursors of [C-11]McN-5652 from racemic McN-5652, J LABEL C R, 42(13), 1999, pp. 1301-1312
Authors:
Vollenweider, FX
Vollenweider-Scherpenhuyzen, MFI
Babler, A
Vogel, H
Hell, D
Citation: Fx. Vollenweider et al., Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action, NEUROREPORT, 9(17), 1998, pp. 3897-3902
Authors:
Vollenweider-Scherpenhuyzen, MFI
Vollenweider, FX
Citation: Mfi. Vollenweider-scherpenhuyzen et Fx. Vollenweider, Emergencies involving drug poisoning, ANAESTHESIS, 47(11), 1998, pp. 946-955
Risultati:
1-22
|